Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Signify health - Caught on Camera

CVS Health (CVS) vs. MedAvail Holdings (MDVL): Which Is the Better Buy?

The drug store industry is well positioned for long-term growth thanks to the growing demand for prescription drugs. Let’s compare CVS Health (CVS) and MedAvail (MDVL) in this space to determine which is better positioned to capitalize on the industry’s solid growth prospects….

StockNews.com

Why CVS Health CEO Karen Lynch wore a 'taking up space' T-shirt on her first day

As CVS starts offering primary care services, the CEO talks full-service health care.

Fortune

3 Stocks with Major Upside Potential

With recent red flags making investors jittery about a not-so-soft landing courtesy of an over-cautious Fed, loading up on fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Ooma (OOMA) could set investors up for market-beating risk-adjusted returns. Continue reading….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

StockNews.com

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

StockNews.com

1 Stock to Buy in Q4 if You Haven't Already

Health service provider CVS Health (CVS) is aiming for an $8 billion acquisition of Signify Health (SGFY). The company’s strength is reflected in its latest quarterly financials. Hence, the stock might be a solid buy in the fourth quarter. Let's find out….

StockNews.com

1 Drugstore Stock to Buy Right Now and 2 to Sell

An ageing population and rising healthcare expenditure due to increased awareness among the masses are expected to boost demand for drugstore products. On the other hand, the stock market is experiencing heightened volatility amid the ongoing macroeconomic challenges. While we think investors should buy drugstore stock CVS Health (CVS), fundamentally…

StockNews.com

2 Stocks to Buy Right Now if You're 50 or Older

With investors fretting about the fate of the global economy amid aggressive interest rate increases, the stock market seems stuck in a vicious loop of volatility. Hence, fundamentally strong stocks with a track record of increasing dividend payouts, Bristol-Myers Squibb (BMY) and CVS Health (CVS), could be considered safe investments…

StockNews.com

Buy These 2 Stocks for a Shot at Some Quick Cash

While aggressive interest rate hikes and consequent market volatility are expected to persist in the foreseeable future, dividend-paying stocks offer investors a steady income. Hence, it would be wise to consider consistent dividend-yielding stocks Phillip Morris (PM) and CVS Healthcare (CVS) for quick risk-adjusted returns. Continue reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022

Upgrades

The Independent UK

CVS to buy home health-care provider Signify for $8 billion

Drugstore operator CVS Health says it's buying home-healthcare provider Signify Health for $8 billion

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

GameStop, Signify Health And Some Other Big Gainers From Monday

U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session.

Benzinga

What 6 Analyst Ratings Have To Say About Signify Health

Over the past 3 months, 6 analysts have published their opinion on Signify Health (NYSE:SGFY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

6 Analysts Have This to Say About Signify Health

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Upgrades

Benzinga

Expert Ratings For Signify Health

Analysts have provided the following ratings for Signify Health (NYSE:SGFY) within the last quarter:

Benzinga

Earnings Outlook For Signify Health

Signify Health (NYSE:SGFY) is set to give its latest quarterly earnings report on Wednesday, 2022-03-02. Here's what investors need to know before the announcement. Analysts estimate that Signify Health will report an earnings per share (EPS) of $0.03.

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.